Intraocular pressure-lowering effects of all commonly used glaucoma drugs: A Meta-analysis of randomized clinical trials

Ophthalmology

Volumn 112, Issue 7, 2005, Pages 1177-1185

  Van Der Valk, Rikkert ^a   Webers, Carroll A B ^a   Schouten, Jan S A G ^a   Zeegers, Maurice P ^b,c   Hendrikse, Fred ^a   Prins, Martin H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETAXOLOL; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; DORZOLAMIDE; LATANOPROST; TIMOLOL; TRAVOPROST;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG EFFECT; EMBASE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MATHEMATICAL MODEL; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; PRESCRIPTIONS, DRUG; PROSTAGLANDINS, SYNTHETIC; RANDOMIZED CONTROLLED TRIALS; TIMOLOL;

EID: 21444433159     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.01.042     Document Type: Article

References (35)

1. H.A. Quigley Number of people with glaucoma worldwide Br J Ophthalmol 80 1996 389 393
2. European Glaucoma Society Terminology and Guidelines for Glaucoma 2nd ed. 2003 Dogma Savona, Italy
3. W.Y. Zhang, A.L. Po, H.S. Dua, A. Azuara-Blanco Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension Br J Ophthalmol 85 2001 983 990
4. T.R. Einarson, N.A. Kulin, D. Tingey, M. Iskedjian Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma Clin Ther 22 2000 1502 1515
5. M.W. van Tulder, W.J. Assendelft, B.W. Koes, L.M. Bouter Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders Spine 22 1997 2323 2330
6. K. Dickersin, Y.I. Min, C.L. Meinert Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards JAMA 267 1992 374 378
7. Alderson P, Green S, Higgins JPT, eds. Locating and selecting studies for reviews. Selecting studies. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. Section 5.2.3. Available at: http://www.cochrane.org/resources/ handbook/hbook.htm. Accessed January 5, 2004.
8. P.J. Easterbrook, J.A. Berlin, R. Gopalan, D.R. Matthews Publication bias in clinical research Lancet 337 1991 867 872
9. A.P. Verhagen, H.C. de Vet, R.A. de Bie The Delphi list a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus J Clin Epidemiol 51 1998 1235 1241
10. V.W. Berger, J.D. Bears When can a clinical trial be called "randomized"? Vaccine 21 2003 468 472
11. V.W. Berger, A. Ivanova, M.D. Knoll Minimizing predictability while retaining balance through the use of less restrictive randomization procedures Stat Med 22 2003 3017 3028
12. V.W. Berger, C.A. Christophi Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias J Modern Appl Stat Methods 2 2003 80 86
13. V.W. Berger, S. Weinstein Ensuring the comparability of comparison groups is randomization enough? Control Clin Trials 25 2004 515 524
14. T.J. Liesegang G.L. Skuta L.B. Cantor 2003-2004 Basic and Clinical Science Course (BCSC) Section 10 Glaucoma 2003 American Academy of Ophthalmology San Francisco
15. A. Kampik, A. Arias-Puente, D.P. O'Brart, M.L. Vuori European Latanoprost Study Group Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension a randomized observer-masked multicenter study J Glaucoma 11 2002 90 96
16. R.H. Stewart, R.L. Kimbrough, R.L. Ward Betaxolol vs timolol. A six-month double-blind comparison Arch Ophthalmol 104 1986 46 48
17. M.V. Aquino, M. Lat-Luna The effect of latanoprost vs timolol on intraocular pressure in patients with glaucoma and ocular hypertension Asian J Ophthalmol 1 1999 3 7
18. E.J. Higginbotham, J.S. Schuman, I. Goldberg Bimatoprost Study Groups 1 and 2. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension Arch Ophthalmol 120 2002 1286 1293
19. J.D. Brandt, A.M. VanDenburgh, K. Chen, S.M. Whitcup Bimatoprost Study Group Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial Ophthalmology 108 2001 1023 1031
20. S.M. Whitcup, L.B. Cantor, A.M. VanDenburgh, K. Chen A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension Br J Ophthalmol 87 2003 57 62
21. R.S. Noecker, M.S. Dirks, N.T. Choplin Bimatoprost/Latanoprost Study Group A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma Am J Ophthalmol 135 2003 55 63
22. P.A. Netland, T. Landry, E.K. Sullivan Travoprost Study Group Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension Am J Ophthalmol 132 2001 472 484
23. R.K. Parrish, P. Palmberg, W.P. Sheu XLP Study Group A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure a 12-week, randomized, masked-evaluator multicenter study Am J Ophthalmol 135 2003 688 703
24. H. DuBiner, D. Cooke, M. Dirks Efficacy and safety of bimatoprost in patients with elevated intraocular pressure a 30-day comparison with latanoprost Surv Ophthalmol 45 suppl 2001 S353 S360
25. J.E. Boyle, K. Ghosh, D.K. Gieser, I.A. Adamsons Dorzolamide-Timolol Study Group A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide Ophthalmology 105 1998 1945 1951
26. E. Strahlman, R. Tipping, R. Vogel International Dorzolamide Study Group A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol Arch Ophthalmol 113 1995 1009 1016
27. STATA [computer program]. Release 8.0. College Station, TX: StataCorp; 2003.
28. M. Egger, G. Davey Smith, M. Schneider, C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
29. Brinzolamide Primary Therapy Study Group K. Sall The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension Surv Ophthalmol 44 suppl 2000 S155 S162
30. M. Egger, G.D. Smith, A.N. Phillips Meta-analysis principles and procedures BMJ 315 1997 1533 1537
31. A.R. Jadad, R.A. Moore, D. Carroll Assessing the quality of reports of randomized clinical trials is blinding necessary? Control Clin Trials 17 1996 1 12
32. G. Gregoire, F. Derderian, J. Le Lorier Selecting the language of the publications included in a meta-analysis is there a Tower of Babel bias? J Clin Epidemiol 48 1995 159 163
33. D. Moher, P. Fortin, A.R. Jadad Completeness of reporting of trials published in languages other than English implications for conduct and reporting of systematic reviews Lancet 347 1996 363 366
34. M. Egger, G.D. Smith Bias in location and selection of studies BMJ 316 1998 61 66
35. Olthoff CMG, Schouten JSAG, van de Borne BW, Webers CAB. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension. An evidence-based review. Ophthalmology. In press.